<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0805014-A6FD-41C1-81BE-B94AE4139F25"><gtr:id>C0805014-A6FD-41C1-81BE-B94AE4139F25</gtr:id><gtr:name>Max Planck Society</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C10A6FA0-189C-4239-96AB-1305D8241B90"><gtr:id>C10A6FA0-189C-4239-96AB-1305D8241B90</gtr:id><gtr:firstName>Sandrine</gtr:firstName><gtr:otherNames>Martine</gtr:otherNames><gtr:surname>Geranton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1100577"><gtr:id>A05451BB-069D-4D49-9D14-D3DAB26ADE2D</gtr:id><gtr:title>Epigenetic modifications and their contribution to persistent pain states</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1100577</gtr:grantReference><gtr:abstractText>In both animals and humans, life experiences leave an enduring trace in the brain. This is associated with so-called epigenetic changes ? structural modifications to DNA that alter the activity of genes without altering the genes themselves. These epigenetic changes are dynamic and reversible but can also result in stable alterations. For example, animal studies have shown that maternal care can modulate the activity of stress-related genes and thus influence the resilience of adult animals to stressful life events. Thus, epigenetics provides a bridge between the genes and the environment, refining neural networks according to experience.
Pain, whether caused through injury, disease or surgery, is usually temporary and serves to protect the body from further injury. As the body heals the pain diminishes and finally disappears. However, in some cases, pain persists and becomes a chronic pain state. Chronic pain is an area of an immense unmet medical need with 19% of adult Europeans suffering from chronic pain of moderate to severe intensity. New and improved treatments are required for these patients as only around one half receive adequate pain management. To develop these treatments we need a better understanding of the mechanisms responsible for the pain that persists after the injury has healed. Could these mechanisms be related to epigenetic processes? I will use my knowledge of pain mechanisms to ask how epigenetic events contribute to the establishment of persistent pain states and more generally modify the plasticity of the nervous system. This proposal will tell us a great deal about the way epigenetic regulators work and how the nervous system adapts to injury. 
By reaching sufficient understanding of these epigenetic mechanisms we will gain insight into the way persistent pain states develop. With this knowledge we will design new and specific pharmacological tools for the treatment of chronic pain. This study will also inform other research on mental retardation and neuropsychiatric disorders since deregulation of epigenetic processes has been associated with a broad spectrum of neurological disorders.</gtr:abstractText><gtr:technicalSummary>Persistent pain, whether caused through injury, disease or surgery, is usually temporary but involves adaptations in the spinal cord nociceptive circuitry, including central sensitization of dorsal horn neurons. This is a complex process that effectively amplifies incoming signals to prevent further damage while the body is repairing. These changes are supported by specific patterns of gene expression that are dynamic and evolve with time. Sometimes the pain persists after the injury has resolved and becomes a chronic pain state indicating maintained sensitization of spinal cord nociceptive networks. Could this be due to aberrant epigenetic modifications?
Epigenetic modifications such as DNA methylation and chromatin remodelling regulate high-order chromatin structure crucial to the regulation of gene expression. Epigenetic processes imprint environmental experiences such as social interactions onto the fixed genome and therefore provide a bridge between the genes and the environment by refining neural networks according to experience. These processes are dynamic and reversible but can also result in stable alterations. Their de-regulation has been associated with a broad spectrum of neurological disorders.
I will investigate the epigenetic processes that contribute to gene repression and activation in dorsal horn neurons in a model of joint inflammation. 1) DNA methylation is known to inhibit gene transcription. I will investigate DNA methylation status of a small number of genes previously identified. 2) Post-translational modifications of histone proteins, specifically at residues known to modify neuronal network function, regulate access to DNA. These modifications will be mapped onto nociceptive pathways during different phases of joint inflammation. 3) Descending controls from the brain and early life injury modulate pain behaviour. I will look at how descending controls and early life injury can regulate DNA methylation and histone modifications and I will investigate the correlation between epigenetic changes and pain behaviour. 4) Finally, to strengthen this correlation, I will modulate the expression of selected genes under epigenetic controls during joint inflammation and analyse their contribution to the pain state. This will include the investigation of micro-RNAs predicted by gene expression analysis and thought to fine tune neural circuits.
This investigation will provide insights into the complex roles of epigenetics in central nervous system plasticity and set the stage for a deeper understanding of the molecular changes that contribute to chronic pain, an area of immense unmet clinical needs.</gtr:technicalSummary><gtr:fund><gtr:end>2016-10-07</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>472543</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Max Planck Society</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Max Planck Institute of Psychiatry</gtr:department><gtr:description>Inhibitors of FKBP51</gtr:description><gtr:id>CE54BC9D-31E2-4A5E-BF93-70BA32152505</gtr:id><gtr:impact>Maiar&amp;ugrave; M., Tochiki K.K., Cox M.B., Annan L.V., Bell C. G., Feng X., Hausch F. and G&amp;eacute;ranton S.M. (2016) The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signalling. Science Translational Medicine. 10; 8(325):325ra19.

Discipline involved:
US: neuroscience, pain and animal behaviour.
Collaborators: chemistry and neuroscience.</gtr:impact><gtr:outcomeId>56d42fbe2bebf4.67873528-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators provide us with state-of-the art inhibitors as well as the information necessary for in vivo use in mice.</gtr:partnerContribution><gtr:piContribution>My team is testing the efficacy of compounds to reduce chronic pain states in rodent models.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press coverage for the FKBP51 study</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BF93BDC8-907F-41F9-8165-ADB5DB1B784C</gtr:id><gtr:impact>I have given a number of interviews for medical websites and blogs. As a result, our work on FKBP51 published January 2016 in Science Translational Medicine is now described in least 50 medical websites / blogs.
1. http://www.medicalnewstoday.com/articles/306359.php
2. http://www.the-scientist.com/?articles.view/articleNo/45305/title/Blocking-a-Stress-Related-Gene-Relieves-Chronic-Pain/
3. http://medicalxpress.com/news/2016-02-blocking-stress-protein-relieves-chronic.html
4. http://www.ucl.ac.uk/news/news-articles/0116/110216-chronic-pain-treatment-mice
5. http://www.upi.com/Health_News/2016/02/11/Chronic-pain-in-mice-relieved-by-blocking-protein/4611455208043/
6. http://www.hngn.com/articles/177944/20160210/chronic-pain-new-study-reveals-relationship-stress-related-protein.html
7. http://www.medicaldaily.com/chronic-pain-stress-protein-373038
8. http://www.forbes.com/sites/emilymullin/2016/02/11/mood-enhancing-drugs-could-also-provide-relief-for-chronic-pain/#7a4352603cd0
9. http://www.bioworld.com/content/stress-chronic-pain-share-common-receptor-0
10. http://www.engineering.ucl.ac.uk/blocking-stress-protein-relieves-chronic-pain-in-mice/
11. http://www.lifescience.net/news/614/blocking-stress-protein-may-relieve-chronic-pain/
12. http://www.counselheal.com/articles/21478/20160212/new-study-reveals-relationship-chronic-pain-stress-related-protein.htm
13. http://www.ndtv.com/health/blocking-stress-protein-relieves-chronic-pain-1276643
14. http://sevilla.abc.es/salud/enfermedades/abci-dolor-cronico-podria-minimizado-farmaco-experimental-para-estres-201602110325_noticia.html
15. http://sahafaharabiah.net/news2786986.html
16. http://www.scienceworldreport.com/articles/37130/20160211/chronic-pain-protein-blocks-problem-in-mice.htm
17. https://www.wessexlifescience.co.uk/news/entry/blocking-stress-protein-relieves-chronic-pain-in-mice
18. http://only24news.com/news?id=50556
19. http://padronel.net/2016/02/12/ms-el-dolor-crnico-podra-ser-minimizado-con-un-frmaco-experimental-para-el-estrs/
20. http://www.graffitiblog.it/bloccando-la-proteina-dello-stress-si-puo-ridurre-il-dolore-cronico364/
21. http://www.infosalus.com/salud-investigacion/noticia-bloquear-proteinas-estres-alivia-dolor-cronico-20160212071933.html
22. http://www.coriglianocalabro.it/index.php/notizie/84-attualita/11556-una-ragazza-di-calabria-che-ce-l-ha-fatta.html
23. http://www.medical-tribune.co.kr/news/articleView.html?idxno=66284
24. http://vashaspina.ru/news/blokirovanie-stressovogo-belka-mozhet-pomoch-umenshit-xronicheskuyu-bol/25382/
25. http://www.cariatinet.it/linizio-di-una-nuova-era-per-lo-sviluppo-di-farmaci-per-il-trattamento-del-dolore-cronico/
26. http://timesofindia.indiatimes.com/life-style/health-fitness/de-stress/Blocking-stress-protein-relieves-chronic-pain/articleshow/50959137.cms
27. http://noticias.lainformacion.com/salud/enfermedad/bloquear-la-proteina-que-provoca-el-estres-podria-ser-la-solucion-al-dolor-cronico_3iLIW9bsuMhb65OPrVTVJ2/
28. http://purebarta.com/blocking-a-stress-supermolecule-might-treat-chronic-pain/
29. http://m.hkn24.com/news/articleView.html?idxno=152405
30. http://www.mundop2p.es/page/3/
31. https://in.news.yahoo.com/blocking-stress-protein-relieves-chronic-pain-073306346.html
32. http://newsfisher.io/article/xXHiPh7aoTdgcdNu6
33. http://diseasestreatment.info/mood-enhancing-drugs-could-also-provide-relief-for-chronic-pain/
34. http://www.sciencecodex.com/blocking_stress_protein_relieves_chronic_pain_in_mice-175358
35. http://www.myscience.org.uk/news/2016/blocking_stress_protein_relieves_chronic_pain_in_mice-2016-UCL
36. http://gephardtdaily.com/health/chronic-pain-mice-relieved-blocking-protein/
37. http://www.breitbart.com/news/chronic-pain-in-mice-relieved-by-blocking-protein/
38. http://www.laboratoryequipment.com/news/2016/02/blocking-stress-protein-relieves-chronic-pain-mice
39. http://www.scienceandtechnologyresearchnews.com/blocking-stress-protein-relieves-chronic-pain-in-mice/
40. http://www.daijiworld.com/news/news_disp.asp?n_id=380350
41. http://www.alnmag.com/news/2016/02/blocking-stress-protein-relieves-chronic-pain-mice
42. http://www.abc.es/salud/enfermedades/abci-dolor-cronico-podria-minimizado-farmaco-experimental-para-estres-201602110325_noticia.html
43. http://styles7.com/2016/02/11/blocking-a-stress-protein-may-treat-chronic-pain/
44. http://www.mangalorean.com/blocking-stress-protein-relieves-chronic-pain/
45. http://www.newkerala.com/news/2016/fullnews-19806.html
46. http://gomedoc.com/blocking-a-stress-protein-may-treat-chronic-pain/
47. http://expofarmacia.com.ar/nota.php?id=2507
48. http://csrproductions.com/chronic-pain-in-mice-relieved-by-blocking-protein/
49. http://www.newsx.com/lifestyle/20502-blocking-stress-protein-relieves-chronic-pain
50. http://www.medicalworldnigeria.com/2016/02/blocking-a-stress-protein-may-treat-chronic-pain/#.Vr7zZLKLSUk
51. http://www.ourladiesandgentlemen.com/medical-news-today-blocking-a-stress-protein-may-treat-chronic-pain/
52. http://www.siasat.com/news/blocking-stress-protein-relieves-chronic-pain-916087/
53. http://www.business-standard.com/article/news-ians/blocking-stress-protein-relieves-chronic-pain-116021200344_1.html
54. http://www.neurexpert.com/blog/Blog24022016.html</gtr:impact><gtr:outcomeId>56d4316bac6245.80045037</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.forbes.com/sites/emilymullin/2016/02/11/mood-enhancing-drugs-could-also-provide-relief-for-chronic-pain/#7a4352603cd0</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>University College London Hospitals Charity (UCLH)</gtr:department><gtr:description>Clinical Research and Development Committee Research Funding from the BRC/UCLH Charities - Fast Track Grant</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>University College London Hospital</gtr:fundingOrg><gtr:fundingRef>168138</gtr:fundingRef><gtr:id>D2E553A2-C96D-4E40-A889-88BB6B5987E2</gtr:id><gtr:outcomeId>56cc42c3e1cfe7.20002583</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Treating chronic pain by inhibiting FKBP51: An investigation in clinically relevant rodent models</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>Pain Relief Foundation</gtr:fundingOrg><gtr:id>C87AD47E-0C38-43A4-8CD9-34702F7195AB</gtr:id><gtr:outcomeId>58ac2a07748be2.31040482</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>663E3201-AC7C-4665-B6AA-43C3609132C1</gtr:id><gtr:title>Synthetic self-assembling clostridial chimera for modulation of sensory functions.</gtr:title><gtr:parentPublicationTitle>Bioconjugate chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d25e20ab73df3cd17093cc62058b2e1f"><gtr:id>d25e20ab73df3cd17093cc62058b2e1f</gtr:id><gtr:otherNames>Ferrari E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1043-1802</gtr:issn><gtr:outcomeId>pm_23803_23_24011174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D0A283D-08F4-4A63-A4F9-E9521C28DACF</gtr:id><gtr:title>Short-term anesthesia inhibits formalin-induced extracellular signal-regulated kinase (ERK) activation in the rostral anterior cingulate cortex but not in the spinal cord.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090c50ba2e59566a3bc4bac0605e41f1"><gtr:id>090c50ba2e59566a3bc4bac0605e41f1</gtr:id><gtr:otherNames>Tochiki KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>5675ea2fdcf98</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B100E0F-F74D-4F81-AF6D-CBEBAFE1FDA3</gtr:id><gtr:title>Regulation of gene expression and pain states by epigenetic mechanisms.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c4deca556ea6acae1c3d2a68fba8016"><gtr:id>3c4deca556ea6acae1c3d2a68fba8016</gtr:id><gtr:otherNames>G?ranton SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>5675e07393958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB04EA67-F290-4AF5-B92F-4FE031CA570F</gtr:id><gtr:title>Could targeting epigenetic processes relieve chronic pain states?</gtr:title><gtr:parentPublicationTitle>Current opinion in supportive and palliative care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3c4deca556ea6acae1c3d2a68fba8016"><gtr:id>3c4deca556ea6acae1c3d2a68fba8016</gtr:id><gtr:otherNames>G?ranton SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1751-4258</gtr:issn><gtr:outcomeId>5675e37087fc1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6574E9D-58D3-4A50-A2AD-45A5E4339CED</gtr:id><gtr:title>Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb8bee4b52d781c4c94da84012a88a95"><gtr:id>bb8bee4b52d781c4c94da84012a88a95</gtr:id><gtr:otherNames>Obara I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>56cc3f23e46c86.57779272</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B9E0F43-3B72-4484-9932-EB135563A54B</gtr:id><gtr:title>The stress regulator FKBP51 drives chronic pain by modulating spinal glucocorticoid signaling.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc65522f360c5a92aae6b84aeb014762"><gtr:id>bc65522f360c5a92aae6b84aeb014762</gtr:id><gtr:otherNames>Maiar? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>56cc3f666b2930.00377174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>865C8A16-6FAA-40EF-B0D6-926FFE4CF711</gtr:id><gtr:title>Nonparalytic botulinum molecules for the control of pain.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/749152e29d76fe183a8ea9ee64410e57"><gtr:id>749152e29d76fe183a8ea9ee64410e57</gtr:id><gtr:otherNames>Mangione AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>56cc3f9ba8f020.47663051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A38B2704-02DD-4B68-A675-AB6BFF4FA9B4</gtr:id><gtr:title>Descending controls modulate inflammatory joint pain and regulate CXC chemokine and iNOS expression in the dorsal horn.</gtr:title><gtr:parentPublicationTitle>Molecular pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2dfa458f27a3da8620f7adc281a41cc7"><gtr:id>2dfa458f27a3da8620f7adc281a41cc7</gtr:id><gtr:otherNames>Carr FB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1744-8069</gtr:issn><gtr:outcomeId>545b5557645694.79765250</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70D22C28-4551-4246-96CC-C09074BA1C1C</gtr:id><gtr:title>The mitogen and stress-activated protein kinase 1 regulates the rapid epigenetic tagging of dorsal horn neurons and nocifensive behaviour.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/090c50ba2e59566a3bc4bac0605e41f1"><gtr:id>090c50ba2e59566a3bc4bac0605e41f1</gtr:id><gtr:otherNames>Tochiki KK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>58bd692f1d0710.75873890</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE92C733-73F0-4F7D-9BC6-B715BFF98A3A</gtr:id><gtr:title>Novel molecular correlates of endocannabinoid-mediated fear-conditioned analgesia in rats.</gtr:title><gtr:parentPublicationTitle>European journal of pain (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8202dde273f8c678fdeb4b9a4d5dd0ca"><gtr:id>8202dde273f8c678fdeb4b9a4d5dd0ca</gtr:id><gtr:otherNames>Olango WM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1090-3801</gtr:issn><gtr:outcomeId>pm_23803_23_23873727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>878724E0-BBA0-444B-8D37-144C0F2BB461</gtr:id><gtr:title>Complex regulation of the regulator of synaptic plasticity histone deacetylase 2 in the rodent dorsal horn after peripheral injury.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc65522f360c5a92aae6b84aeb014762"><gtr:id>bc65522f360c5a92aae6b84aeb014762</gtr:id><gtr:otherNames>Maiar? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>585d3a03aec492.67736628</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D599CD0-B023-4BE7-9258-AF709F5FFD64</gtr:id><gtr:title>The Stress Regulator Fkbp51: A Novel and Promising Druggable Target for the Treatment of Persistent Pain States Across Sexes.</gtr:title><gtr:parentPublicationTitle>Pain</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc65522f360c5a92aae6b84aeb014762"><gtr:id>bc65522f360c5a92aae6b84aeb014762</gtr:id><gtr:otherNames>Maiar? M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0304-3959</gtr:issn><gtr:outcomeId>5aa90241f07085.79554233</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1100577</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>